关于异基因造血干细胞移植后对急性髓系白血病患者的影响。（你提供的原文有缺失部分，这里是根据现有内容尽量完整翻译） - Suppr

Suppr

超能文献

The Impact of on Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.

作者信息

Su Long

机构信息

Jilin University First Hospital, Clinic of Hematology, Changchun, China

出版信息

Turk J Haematol. 2019 Feb 7;36(1):64-66. doi: 10.4274/tjh.galenos.2018.2018.0274. Epub 2018 Oct 22.

DOI:10.4274/tjh.galenos.2018.2018.0274

PMID:30346304

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6373500/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0273/6373500/54f191cb599a/TJH-36-64-g1.jpg

相似文献

The Impact of on Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.

Turk J Haematol. 2019 Feb 7;36(1):64-66. doi: 10.4274/tjh.galenos.2018.2018.0274. Epub 2018 Oct 22.

FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.

Turk J Haematol. 2018 Aug 3;35(3):158-167. doi: 10.4274/tjh.2018.0017. Epub 2018 May 22.

[Effect of FLT3-ITD with DNMT3A R882 double-mutation on the prognosis of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].

Zhonghua Xue Ye Xue Za Zhi. 2018 Jul 14;39(7):552-557. doi: 10.3760/cma.j.issn.0253-2727.2018.07.005.

DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2016 Jan;22(1):61-70. doi: 10.1016/j.bbmt.2015.07.030. Epub 2015 Jul 31.

Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.

Ann Hematol. 2016 Mar;95(4):625-35. doi: 10.1007/s00277-015-2580-z. Epub 2015 Dec 22.

Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.

Biol Blood Marrow Transplant. 2016 Mar;22(3):462-9. doi: 10.1016/j.bbmt.2015.10.023. Epub 2015 Nov 10.

Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study.

Am J Hematol. 2012 Dec;87(12):1052-6. doi: 10.1002/ajh.23311. Epub 2012 Aug 22.

DNMT3A (R882) mutation features and prognostic effect in acute myeloid leukemia in Coexistent with NPM1 and FLT3 mutations.

Hematol Oncol Stem Cell Ther. 2018 Jun;11(2):82-89. doi: 10.1016/j.hemonc.2017.09.004. Epub 2017 Oct 18.

A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation.

Ann Hematol. 2014 Feb;93(2):293-8. doi: 10.1007/s00277-013-1858-2. Epub 2013 Aug 2.

FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics.

Turk J Haematol. 2017 Dec 1;34(4):300-306. doi: 10.4274/tjh.2016.0489. Epub 2017 Mar 15.

引用本文的文献

Clinical Characteristics and Outcomes of Acute Myeloid Leukemia Patients Harboring Triple Mutations and the Potential Prognostic Value of .

Cancer Control. 2025 Jan-Dec;32:10732748251359836. doi: 10.1177/10732748251359836. Epub 2025 Jul 17.

Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.

PLoS One. 2021 Apr 28;16(4):e0243683. doi: 10.1371/journal.pone.0243683. eCollection 2021.

本文引用的文献

Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in mutated acute myeloid leukemia.

Oncotarget. 2018 Nov 27;9(93):36613-36624. doi: 10.18632/oncotarget.26400.

FLT3-ITD and CEBPA Mutations Predict Prognosis in Acute Myelogenous Leukemia Irrespective of Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant. 2019 May;25(5):941-948. doi: 10.1016/j.bbmt.2018.11.031. Epub 2018 Nov 29.

Biological and clinical influences of in acute myeloid leukemia patients with mutations.

Cancer Manag Res. 2018 Aug 7;10:2489-2497. doi: 10.2147/CMAR.S166714. eCollection 2018.

Turk J Haematol. 2018 Aug 3;35(3):158-167. doi: 10.4274/tjh.2018.0017. Epub 2018 May 22.

High -mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.

Blood. 2018 Jun 21;131(25):2816-2825. doi: 10.1182/blood-2018-01-828467. Epub 2018 May 3.

Genomic Classification and Prognosis in Acute Myeloid Leukemia.

N Engl J Med. 2016 Jun 9;374(23):2209-2221. doi: 10.1056/NEJMoa1516192.

Quantitative fragment analysis of FLT3-ITD efficiently identifying poor prognostic group with high mutant allele burden or long ITD length.

Blood Cancer J. 2015 Aug 14;5(8):e336. doi: 10.1038/bcj.2015.61.

Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations.

J Hematol Oncol. 2014 Oct 4;7:74. doi: 10.1186/s13045-014-0074-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验